Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma
Clinical trial NCT04713761 · UNKNOWN
Trial details
- NCT number
- NCT04713761
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2022-01-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.